Heathcare startup MedTel to raise around USD 10mn in Series A
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Plant is part of the company's CAD $30 million capital investment in the site
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Themis Medicare’s VIRALEX is an effective and safe drug for management of mild to moderate COVID and other acute viral respiratory infections.
Fermentation-based manufacturing leverages Evonik’s biotechnology platform
The company has been issued a Form 483 with two observations which the company will address within the stipulated timeline.
This GMP and Pre-Approval Inspection is part of the routine business operations and the company shall submit to US FDA within the stipulated timeline
Subscribe To Our Newsletter & Stay Updated